Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dong-A Socio Holdings Co., Ltd. (000640:KRX), powered by AI.
Dong-A Socio Holdings Co., Ltd. is currently trading at ₩95,000. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Dong-A Socio Holdings Co., Ltd. on Alpha Lenz.
Dong-A Socio Holdings Co., Ltd.'s P/E ratio is 10.5.
“Dong-A Socio Holdings Co., Ltd. trades at a P/E of 10.5 (undervalued) with modest ROE of 5.6%. 3Y revenue CAGR of 14.8% highlights clear growth momentum.”
Ask for details →Dong-A Socio Holdings Co., Ltd. is a prominent holding company in South Korea, primarily focusing on pharmaceutical development, healthcare, and related sectors. As a holding entity, its main purpose is to oversee and manage a portfolio of subsidiaries that are involved in various stages of drug development, production, and distribution. Dong-A Socio Holdings plays a critical role in the pharmaceutical industry, engaging in research to advance medical breakthroughs and improve healthcare outcomes. With diversified interests that also span consumer healthcare products and biotechnology, the company underscores its commitment to addressing a wide array of health-related needs. In the financial market, Dong-A Socio Holdings serves as a key participant in South Korea's economic landscape by fostering innovation within the healthcare sector and contributing to the overall growth of the pharmaceutical industry. This positioning not only strengthens its market presence but also enhances its influence in shaping health-related policies and practices.
“Dong-A Socio Holdings Co., Ltd. trades at a P/E of 10.5 (undervalued) with modest ROE of 5.6%. 3Y revenue CAGR of 14.8% highlights clear growth momentum.”
Ask for details →Dong-A Socio Holdings Co., Ltd. (ticker: 000640) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 83 employees. Market cap is $621.0B.
The current price is ₩95,000 with a P/E ratio of 10.54x and P/B of 0.58x.
ROE is 5.63% and operating margin is 6.16%. Annual revenue is $1.3T.